Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 10, 2010 - Issue 6
Submit an article Journal homepage
309
Views
59
CrossRef citations to date
0
Altmetric
Review

Using ‘omics’ to define pathogenesis and biomarkers of Parkinson’s disease

W Michael Caudle University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA; University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA
,
Theo K Bammler University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA; University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA
,
Yvonne Lin University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA; University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA
,
Sheng Pan University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA; University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA
&
Jing Zhang University of Washington, Seattle, WA, USA; Department of Pathology, University of Washington School of Medicine, HMC Box 359635, 325 9th Ave., Seattle, WA 98104, USA;[email protected]
Pages 925-942 | Published online: 09 Jan 2014

Citations (59)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Nilanjana Ghosh, Mainak Dutta, Brajesh Singh, Rintu Banerjee, Parthasarathi Bhattacharyya & Koel Chaudhury. (2016) Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update. Expert Review of Molecular Diagnostics 16:8, pages 897-913.
Read now
Claire Henchcliffe. (2015) Blood and cerebrospinal fluid markers in Parkinson's disease: current biomarker findings. Current Biomarker Findings 5, pages 1-11.
Read now
Kina Höglund & Hugh Salter. (2013) Molecular biomarkers of neurodegeneration. Expert Review of Molecular Diagnostics 13:8, pages 845-861.
Read now

Articles from other publishers (56)

Hasan Turkez, Ozlem Altay, Serkan Yildirim, Xiangyu Li, Hong Yang, Cemil Bayram, Ismail Bolat, Sena Oner, Ozlem Ozdemir Tozlu, Mehmet Enes Arslan, Muhammad Arif, Burak Yulug, Lutfu Hanoglu, Seyda Cankaya, Simon Lam, Halil Aziz Velioglu, Ebru Coskun, Ezgi Idil, Rahim Nogaylar, Ahmet Ozsimsek, Ahmet Hacimuftuoglu, Saeed Shoaie, Cheng Zhang, Jens Nielsen, Jan Borén, Mathias Uhlén & Adil Mardinoglu. (2023) Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases. Life Sciences 314, pages 121325.
Crossref
Peter A. LeWitt, Jia Li, Kuan-Han Wu & Mei Lu. (2022) Diagnostic metabolomic profiling of Parkinson's disease biospecimens. Neurobiology of Disease, pages 105962.
Crossref
Joel Arvin Rodrigues, Rekha K. Narasimhamurthy, Manjunath B. Joshi, Herman Sunil Dsouza & Kamalesh Dattaram Mumbrekar. (2022) Pesticides Exposure-Induced Changes in Brain Metabolome: Implications in the Pathogenesis of Neurodegenerative Disorders. Neurotoxicity Research 40:5, pages 1539-1552.
Crossref
Oscar Salvador Barrera-Vázquez, Elizabeth Sulvaran-Guel, Gibrán Pedraza-Vázquez & Juan Carlos Gomez-Verjan. 2022. Principles of Genetics and Molecular Epidemiology. Principles of Genetics and Molecular Epidemiology 189 201 .
Alexandra Benchoua, Marie Lasbareilles & Johana Tournois. (2021) Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders. Cells 10:12, pages 3290.
Crossref
Yanhui Deng, Ping Shuai, Haixin Wang, Shanshan Zhang, Jie Li, Mingyan Du, Peirong Huang, Chao Qu & Lulin Huang. (2021) Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration. Aging 13:10, pages 13968-14000.
Crossref
Della G.T. Parambi. (2020) Treatment of Parkinson’s Disease by MAO-B Inhibitors, New Therapies and Future Challenges - A Mini-Review. Combinatorial Chemistry & High Throughput Screening 23:9, pages 847-861.
Crossref
Shubhra Acharya, Antonio Salgado-Somoza, Francesca Maria Stefanizzi, Andrew I. Lumley, Lu Zhang, Enrico Glaab, Patrick May & Yvan Devaux. (2020) Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease. International Journal of Molecular Sciences 21:18, pages 6513.
Crossref
Yanan Tang, Caley B. Craven, Nicholas J.P. Wawryk, Junlang Qiu, Feng Li & Xing-Fang Li. (2020) Advances in mass spectrometry-based omics analysis of trace organics in water. TrAC Trends in Analytical Chemistry 128, pages 115918.
Crossref
Tim Ahfeldt, Alban Ordureau, Christina Bell, Lily Sarrafha, Chicheng Sun, Silvia Piccinotti, Tobias Grass, Gustavo M. Parfitt, Joao A. Paulo, Fumiki Yanagawa, Takayuki Uozumi, Yasujiro Kiyota, J. Wade Harper & Lee L. Rubin. (2020) Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons. Stem Cell Reports 14:1, pages 75-90.
Crossref
Alika Sarkar, Neeraj Rawat, Nidhi Sachan & Mahendra Pratap Singh. (2019) Unequivocal Biomarker for Parkinson’s Disease: A Hunt that Remains a Pester. Neurotoxicity Research 36:3, pages 627-644.
Crossref
Ellen R. Weiss, Shoji Osawa, Yubin Xiong, Suraj Dhungana, James Carlson, Susan McRitchie & Timothy R. Fennell. (2019) Broad spectrum metabolomics for detection of abnormal metabolic pathways in a mouse model for retinitis pigmentosa. Experimental Eye Research 184, pages 135-145.
Crossref
Craig Pickering & John Kiely. (2019) The Development of a Personalised Training Framework: Implementation of Emerging Technologies for Performance. Journal of Functional Morphology and Kinesiology 4:2, pages 25.
Crossref
Carolina Cardona, Eliana Benincore, Natalia Pimentel, Luis H. Reyes, Camilo Patarroyo, Alexander Rodríguez-López, M. Martin-Rufian, Luis Alejandro Barrera & Carlos J. Alméciga-Díaz. (2019) Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain. Heliyon 5:5, pages e01667.
Crossref
Runcheng He, Xinxiang Yan, Jifeng Guo, Qian Xu, Beisha Tang & Qiying Sun. (2018) Recent Advances in Biomarkers for Parkinson’s Disease. Frontiers in Aging Neuroscience 10.
Crossref
Marta Cherubini & Richard Wade-Martins. (2017) Convergent pathways in Parkinson’s disease. Cell and Tissue Research 373:1, pages 79-90.
Crossref
Emily L. Gill, Jeremy P. Koelmel, Richard A. Yost, Michael S. Okun, Vinata Vedam-Mai & Timothy J. Garrett. (2018) Mass Spectrometric Methodologies for Investigating the Metabolic Signatures of Parkinson’s Disease: Current Progress and Future Perspectives. Analytical Chemistry 90:5, pages 2979-2986.
Crossref
Albert Stezin, Rajini M. Naduthota, Ragasudha Botta, Shriram Varadharajan, Abhishek Lenka, Jitender Saini, Ravi Yadav & Pramod Kumar Pal. (2017) Clinical utility of visualisation of nigrosome-1 in patients with Parkinson’s disease. European Radiology 28:2, pages 718-726.
Crossref
Sara RedenšekVita DolžanTanja Kunej. (2018) From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms. OMICS: A Journal of Integrative Biology 22:1, pages 1-16.
Crossref
Peter A. LeWittJia LiMei LuLining GuoPeggy Auinger. (2017) Metabolomic biomarkers as strong correlates of Parkinson disease progression. Neurology 88:9, pages 862-869.
Crossref
Affif Zaccaria, Ali Bouamrani, Stephan Chabardès, Michèle El Atifi, Eric Seigneuret, Johannes A. Lobrinus, Michel Dubois-Dauphin, François Berger & Pierre R. Burkhard. (2016) Deep brain stimulation-associated brain tissue imprints: a new in vivo approach to biological research in human Parkinson’s disease. Molecular Neurodegeneration 11:1.
Crossref
Sumit Sarkar, James Raymick & Syed Imam. (2016) Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives. International Journal of Molecular Sciences 17:6, pages 904.
Crossref
Thomas F. Tropea & Claire Henchcliffe. 2016. Parkinson's Disease. Parkinson's Disease 249 264 .
. 2016. Parkinson's Disease. Parkinson's Disease 231 360 .
Marion Delenclos, Daryl R. Jones, Pamela J. McLean & Ryan J. Uitti. (2016) Biomarkers in Parkinson's disease: Advances and strategies. Parkinsonism & Related Disorders 22, pages S106-S110.
Crossref
Arvind Kumar Shukla, Ch. Ratnasekhar, Prakash Pragya, Hitesh Singh Chaouhan, Devendra Kumar Patel, Debapratim Kar Chowdhuri & Mohana Krishna Reddy Mudiam. (2014) Metabolomic Analysis Provides Insights on Paraquat-Induced Parkinson-Like Symptoms in Drosophila melanogaster. Molecular Neurobiology 53:1, pages 254-269.
Crossref
Xiangmin Lin, Min Shi, Jeyaraj Gunasingh Masilamoni, Romel Dator, James Movius, Patrick Aro, Yoland Smith & Jing Zhang. (2015) Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1854:7, pages 779-787.
Crossref
Weijian Zhang, Lina Zhou, Peiyuan Yin, Jinbing Wang, Xin Lu, Xiaomei Wang, Jianguo Chen, Xiaohui Lin & Guowang Xu. (2015) A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma. Scientific Reports 5:1.
Crossref
Nadia Magdalinou, Andrew J Lees & Henrik Zetterberg. (2014) Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions. Journal of Neurology, Neurosurgery & Psychiatry 85:10, pages 1065-1075.
Crossref
Brigit E. Riley, Shyra J. Gardai, Dorothea Emig-Agius, Marina Bessarabova, Alexander E. Ivliev, Birgit Schüle, Jeff Alexander, William Wallace, Glenda M. Halliday, J. William Langston, Scott Braxton, Ted Yednock, Thomas Shaler & Jennifer A. Johnston. (2014) Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms. PLoS ONE 9:8, pages e102909.
Crossref
Tiziana Alberio, Kelly McMahon, Manuela Cuccurullo, Lee A. Gethings, Craig Lawless, Maurizio Zibetti, Leonardo Lopiano, Johannes P. C. Vissers & Mauro Fasano. (2014) Verification of a Parkinson’s Disease Protein Signature in T-Lymphocytes by Multiple Reaction Monitoring. Journal of Proteome Research 13:8, pages 3554-3561.
Crossref
Lien-Yu Hung, Hui-Wen Wu, Kuangwen Hsieh & Gwo-Bin Lee. (2014) Microfluidic platforms for discovery and detection of molecular biomarkers. Microfluidics and Nanofluidics 16:5, pages 941-963.
Crossref
Xing Zhang, Veronica M. Chiu, George Stoica, Gina Lungu, James O. Schenk & Herbert H. HillJr.Jr.. (2014) Metabolic Analysis of Striatal Tissues from Parkinson’s Disease-like Rats by Electrospray Ionization Ion Mobility Mass Spectrometry. Analytical Chemistry 86:6, pages 3075-3083.
Crossref
Gerald A. Dienel. 2014. From Molecules to Networks. From Molecules to Networks 53 117 .
Frazer Lowe. 2014. Systems Biology of Free Radicals and Antioxidants. Systems Biology of Free Radicals and Antioxidants 65 87 .
Peter A. LeWitt, Jia Li, Mei Lu, Thomas G. Beach, Charles H. Adler & Lining Guo. (2013) 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis. Movement Disorders 28:12, pages 1653-1660.
Crossref
Sushil Sharma, Carolyn Seungyoun Moon, Azza Khogali, Ali Haidous, Anthony Chabenne, Comfort Ojo, Miriana Jelebinkov, Yousef Kurdi & Manuchair Ebadi. (2013) Biomarkers in Parkinson’s disease (recent update). Neurochemistry International 63:3, pages 201-229.
Crossref
Melissa P. Osborn, Youngja Park, Megan B. Parks, L. Goodwin Burgess, Karan Uppal, Kichun Lee, Dean P. Jones & Milam A. Brantley. (2013) Metabolome-Wide Association Study of Neovascular Age-Related Macular Degeneration. PLoS ONE 8:8, pages e72737.
Crossref
Affif Zaccaria, Ali Bouamrani, Laurent Selek, Michelle El Atifi, Anne Marie HesseAurélie Juhem, David Ratel, Herve Mathieu, Yohann CouteChristophe BruleyJerome GarinAlim L Benabid, Stephan Chabardes, Brigitte Piallat & François Berger. (2013) A Micro-Silicon Chip for in Vivo Cerebral Imprint in Monkey . ACS Chemical Neuroscience 4:3, pages 385-392.
Crossref
. (2013) Is clinical proteomics heading towards to “bench to bedside”?. Translational Proteomics 1:1, pages 53-56.
Crossref
Peter A. LeWitt, Bertrand R. Huber & Jing Zhang. 2013. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future 161 184 .
Brian R Haas, Tessandra H Stewart & Jing Zhang. (2012) Premotor biomarkers for Parkinson's disease - a promising direction of research. Translational Neurodegeneration 1:1.
Crossref
Tiziana Alberio, Agnese C. Pippione, Cristoforo Comi, Simone Olgiati, Daniela Cecconi, Maurizio Zibetti, Leonardo Lopiano & Mauro Fasano. (2012) Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease. IUBMB Life 64:10, pages 846-852.
Crossref
Karin D. van Dijk, Henk W. Berendse, Benjamin Drukarch, Silvina A. Fratantoni, Thang V. Pham, Sander R. Piersma, Evelien Huisman, John J.P. Brevé, Henk J. Groenewegen, Connie R. Jimenez & Wilma D.J. van de Berg. (2012) The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis. Brain Pathology 22:4, pages 485-498.
Crossref
Vaibhav Singh, Rogier Q. Hintzen, Theo M. Luider & Marcel P. Stoop. (2012) Proteomics technologies for biomarker discovery in multiple sclerosis. Journal of Neuroimmunology 248:1-2, pages 40-47.
Crossref
I. Ferrer, I. López-Gonzalez, M. Carmona, E. Dalfó, A. Pujol & A. Martínez. (2012) Neurochemistry and the non-motor aspects of PD. Neurobiology of Disease 46:3, pages 508-526.
Crossref
Brit Mollenhauer & Jing Zhang. (2012) Biochemical premotor biomarkers for Parkinson's disease. Movement Disorders 27:5, pages 644-650.
Crossref
Rivka Ravid & Isidro Ferrer. (2012) Brain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson’s disease. The FEBS Journal 279:7, pages 1167-1176.
Crossref
Yoland Smith, Thomas Wichmann, Stewart A Factor & Mahlon R DeLong. (2011) Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa. Neuropsychopharmacology 37:1, pages 213-246.
Crossref
Claire Henchcliffe, Richard Dodel & M. Flint Beal. (2011) Biomarkers of Parkinson's disease and Dementia with Lewy bodies. Progress in Neurobiology 95:4, pages 601-613.
Crossref
Tiziana Alberio & Mauro Fasano. (2011) Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies. Journal of Biotechnology 156:4, pages 325-337.
Crossref
Angelo D'Alessandro, Sara Rinalducci & Lello Zolla. (2011) Redox proteomics and drug development. Journal of Proteomics 74:12, pages 2575-2595.
Crossref
Jia Liu, Lawrence Litt, Mark R. Segal, Mark J. S. Kelly, Jeffrey G. Pelton & Myungwon Kim. (2011) Metabolomics of Oxidative Stress in Recent Studies of Endogenous and Exogenously Administered Intermediate Metabolites. International Journal of Molecular Sciences 12:10, pages 6469-6501.
Crossref
. (2011) Current World Literature. Current Opinion in Neurology 24:4, pages 409-413.
Crossref
Carol B. Fowler, Ingrid E. Chesnick, Cedric D. Moore, Timothy J. O'Leary & Jeffrey T. Mason. (2010) Elevated Pressure Improves the Extraction and Identification of Proteins Recovered from Formalin-Fixed, Paraffin-Embedded Tissue Surrogates. PLoS ONE 5:12, pages e14253.
Crossref
E. Dudley, M. Yousef, Y. Wang & W.J. Griffiths. 2010. 45 83 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.